Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04851301 · ClinicalTrials.gov registry record · Phase 1
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain
A Phase 1 study of Pain and Virtual Reality, sponsored by University of Maryland, Baltimore.
- Active
- Registry status
- Phase 1
- Development phase
- 259
- Enrollment target
- 1
- Study location
NCT04851301 is a Phase 1 study of Pain and Virtual Reality that is active but no longer recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 259 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04851301, a Phase 1 study of Pain and Virtual Reality, is active but no longer recruiting, sponsored by University of Maryland, Baltimore.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 259 participants
- Enrollment target
- 1
- Study location
Study Summary
This project examines, in chronic pain, the mechanisms of immersive virtual reality compared to the mechanisms of placebo hypoalgesia. The potential of developing new non-pharmacological premises for low-risk interventions for pain management is high.
Conditions Studied
Interventions
- OTHER Saline
- OTHER No Intervention
- DRUG Naloxone
- BEHAVIORAL Active Virtual Reality
- BEHAVIORAL sham Virtual Reality
Study Locations (1)
Maryland
- Luana Colloca - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 259 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2026-11-30 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04851301
The ClinicalTrials.gov registry entry for NCT04851301 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 259 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (15% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Pain appearing as the primary indexed condition, and to 5 interventions - of which Saline is the first listed.
NCT04851301 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04851301 about?
NCT04851301 is a clinical study titled "Neural Mechanisms of Immersive Virtual Reality in Chronic Pain". This project examines, in chronic pain, the mechanisms of immersive virtual reality compared to the mechanisms of placebo hypoalgesia. The potential of developing new non-pharmacological premises for low-risk interventions for pain management is high.
What is the current status of trial NCT04851301?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 259 participants. The study started on 2021-11-01. Estimated completion is 2026-11-30.
What conditions does trial NCT04851301 study?
This clinical trial studies the following conditions: Pain, Virtual Reality, Placebo, Temporomandibular Disorder.
What interventions are being tested in trial NCT04851301?
The interventions under investigation include: Saline (OTHER), No Intervention (OTHER), Naloxone (DRUG), Active Virtual Reality (BEHAVIORAL), sham Virtual Reality (BEHAVIORAL).
Who is sponsoring clinical trial NCT04851301?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04851301 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
RECRUITING · Phase 1
-
Evaluation of the Excretion of Suzetrigine Into Breast Milk in Healthy Lactating Female Participants
RECRUITING · Phase 1
-
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
RECRUITING · Phase 1
-
High Potency Cannabis: Acute and Protracted Effects
RECRUITING · Phase 1
-
Phase 1 Study of SBS-147 in Healthy Adults
RECRUITING · Phase 1
-
Patient Controlled Administration of Liquid Acetaminophen
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.